Journal of Cancer Research and Therapeutics Close
 

Figure 1: Effect of myricetin on the viability of cholangiocarcinoma cells. KKU-100 cells were treated with various concentrations of myricetin for 24 h. After treatment, the cell viability was determined by using the sulforhodamine B assay. Each bar represents the mean ± standard deviation of three independent experiments

Figure 1: Effect of myricetin on the viability of cholangiocarcinoma cells. KKU-100 cells were treated with various concentrations of myricetin for 24 h. After treatment, the cell viability was determined by using the sulforhodamine B assay. Each bar represents the mean ± standard deviation of three independent experiments